Financial Information

10/10/2019 - 7:30 am | Press releases

DBV Technologies Announces Full Exercise of Underwriters’ Option to Purchase Additional Shares in Connection With its Global Offering of Ordinary Shares in the Form of American Depositary Shares (ADSs)

10/09/2019 - 7:30 am

DBV Technologies Announces Pricing of $125 million (€114 million) Global Offering of Ordinary Shares, Including in the Form of American Depositary Shares

10/08/2019 - 10:15 pm | Press releases

DBV Technologies Announces the Launch of a Proposed Global Offering of Ordinary Shares, Which May Be in the Form of American Depositary Shares, and Reports September 30, 2019 Cash Position

10/04/2019 - 5:45 pm

DBV Technologies Announces FDA Acceptance of BLA filing for Viaskin Peanut for the Treatment of Peanut Allergy

10/02/2019 - 10:00 pm

Monthly information regarding the total number of voting rights and total number of shares of the Company

08/01/2019 - 7:30 am | Finance

DBV Technologies Reports First Half 2019 Financial Results

08/01/2019 - 7:30 am | Finance

Half-year financial report 2019

05/13/2019 - 5:08 pm | General Assembly

Annual General Meeting, May 24, 2019

Statutory Auditors’ supplementary report on the share capital increase with cancellation of preferential subscription rights
Combined Shareholders’ Meeting of May 24, 2019
Download PDF (222 KB)

05/13/2019 - 5:02 pm | General Assembly

Annual General Meeting, May 24, 2019

Statutory Auditors’ report on the authorization to grant share subscription and/or share purchase options
Combined Shareholders’ Meeting of May 24, 2019 – 28th resolution
Download PDF (171 KB)

05/13/2019 - 5:00 pm | General Assembly

Annual General Meeting, May 24, 2019

Statutory Auditors’ report on the authorization to grant free shares (existing and/or to be issued) to employees and/or certain corporate officers
Combined Shareholders’ Meeting of May 24, 2019 – 27th resolution
Download PDF (191 KB)